Protopic
In brief
- Protopic is officially a prescription-only medicine in virtually all markets (including USA and EU) and is supplied via pharmacies and licensed online pharmacies; however, in practice some e‑pharmacies or local suppliers may list it without requiring a prescription—buying without a valid prescription is not the official route and you should exercise caution.
- Protopic (tacrolimus ointment) is used to treat moderate‑to‑severe atopic dermatitis/eczema; it is a topical calcineurin inhibitor that reduces T‑cell activation and inflammatory cytokine release in the skin.
- Usual dosage: apply a thin layer of 0.03% or 0.1% ointment to affected areas twice daily until symptoms clear (children 2–15 years: 0.03% only); for maintenance some patients use once or twice weekly to previous lesions; not approved for children under 2.
- Form of administration: topical ointment applied to the skin; do not apply to mucous membranes, open wounds or under occlusive dressings.
- Onset time: symptomatic improvement is often seen within days, with clearer resolution commonly within 1–3 weeks of regular twice‑daily use; local stinging/burning can occur immediately after application.
- Duration of action: effects persist while treatment is continued; maintenance regimens (once or twice weekly) can reduce recurrences, and studies have assessed long‑term use (up to several years) in selected patients.
- Alcohol warning: there is no major systemic interaction, but some users report flushing or increased sensitivity after alcohol intake following application—avoid alcohol if you notice such reactions and discuss with your clinician.
- The most common side effec is local burning or stinging at the application site; other common effects include itching, erythema, tingling, and occasionally folliculitis or local viral infections.
- Would you like to try Protopic without a prescription?
Basic Protopic Information
- INN (International Nonproprietary Name): Tacrolimus.
- Brand Names Available In Australia: Protopic (marketed internationally in USA, EU, Japan and others) and various generics such as Tacrolimus Sandoz and Indian generics are noted in supplier lists; local availability may vary and specific Australian brand listings are not specified in the source data.
- ATC Code: D11AH01 (Tacrolimus — topical calcineurin inhibitors).
- Forms & Dosages: Ointment 0.03% for children aged ≥2 years and adults, and ointment 0.1% for adults and adolescents ≥16 years; common tube sizes include 30 g and 60 g depending on market.
- Manufacturers In Australia: Original manufacturer is Astellas Pharma (global); generics are supplied by firms such as Sandoz, Glenmark, Intas, Cipla and others, but local Australian sponsors/stockists should be checked via ARTG.
- Registration Status In Australia: Prescription-only status is the prevailing classification internationally; specific ARTG entries and local registration details must be checked on the TGA/ARTG for current Australian listings as the raw data does not specify an Australian registration entry.
- OTC / Rx Classification: Prescription only (Rx) in the markets reviewed — not an over‑the‑counter medicine.
Critical Warnings & Restrictions
Worried about who should avoid tacrolimus ointment and when?
High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)
Absolute contraindications include known hypersensitivity to tacrolimus or any ointment excipients and active skin infections such as herpes simplex or varicella.
Patients who are immunocompromised (for example post‑transplant patients, people with HIV or those on systemic immunosuppressants) should avoid topical tacrolimus or be monitored closely because of labelled warnings and theoretical cancer risk.
Those with a personal or family history of skin cancer or premalignant lesions require careful assessment and specialist input before use.
Pregnant and breastfeeding women should only use tacrolimus ointment if the expected benefit justifies potential risks, and after specialist advice.
Elderly patients may have an altered skin barrier and should be monitored for increased irritation or secondary infection despite no routine dose change being required.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Topical tacrolimus is not sedating and generally does not impair driving or machinery operation.
If a patient develops severe local reactions, systemic symptoms (rare), dizziness or significant discomfort after application, they should avoid driving or operating heavy machinery until assessed.
Workplace safety rules in Australia require staff to report any impairment that could affect safety; clinicians and pharmacists should advise employees accordingly if they experience adverse effects.
Q&A — “Can I Drive After Taking It In Australia?”
Generally yes — topical tacrolimus has minimal systemic absorption and is not known to impair driving.
Stop driving and seek medical advice if you feel unwell, dizzy or faint after applying the ointment.
Immediate red flags checklist: severe local burning or swelling, spreading redness suggesting infection, new blisters or systemic symptoms such as fever or lightheadedness.
Contact your GP or local pharmacist if any of the red flags occur.
Usage Basics
Do you need quick facts on what the medicine is called and how it’s regulated?
INN, Brand Names Available In Australia
The International Nonproprietary Name (INN) is tacrolimus.
Protopic is the originator brand used in many countries; generics such as Tacrolimus Sandoz and various international generics exist and local Australian brand presence should be confirmed with the pharmacy or via ARTG.
Legal Classification (TGA‑Approved, PBS‑Listed)
Tacrolimus topical formulations are prescription‑only medicines in the reviewed markets and must be supplied on prescription via a pharmacy.
Check the TGA and ARTG for current sponsor entries and the PBS schedules for subsidy status as availability and subsidy can change.
- INN: Tacrolimus.
- ATC: D11AH01 — topical calcineurin inhibitors.
- Formulation: Ointment.
- Concentrations: 0.03% and 0.1%.
Common presentations you may see in Australia include 0.03% ointment tubes and 0.1% ointment tubes, often in 30 g or 60 g sizes, subject to supplier stock.
Prescription only — no over‑the‑counter supply; Australian pharmacies accept e‑prescriptions and telehealth scripts from authorised prescribers.
Dosing Guide
Want to know how to apply tacrolimus safely and what to do if a dose is missed?
Standard Regimens (PBS Reference Dosing)
Apply a thin layer of tacrolimus ointment to the affected area twice daily until symptoms clear, which is commonly within 1–3 weeks.
For maintenance and relapse prevention, once or twice weekly application to previously affected sites is used in some regimens aligned with EMA guidance.
Use 0.03% for children aged 2–15 years and either 0.03% or 0.1% for adults and adolescents ≥16 years based on severity and prescriber judgement.
Adjustments For Comorbidities
No routine topical dose change is required for elderly patients or for those with hepatic or renal impairment because systemic absorption is generally minimal.
Monitor patients with very thin, inflamed or widely denuded skin more closely because higher absorption can occur in these situations.
Avoid application to open wounds, mucous membranes or under occlusion and avoid combining with other potent topical immunosuppressants without medical advice.
Q&A — “What If I Miss A Dose?”
Apply as soon as you remember unless the next application is due shortly.
Do not double the dose to make up for a missed application.
- Apply a thin layer only to affected areas.
- Wash hands after applying unless treating the hands themselves.
- Avoid immediate sun or UV exposure on treated skin.
Interaction Chart
Curious if tacrolimus ointment mixes with food, alcohol or other medicines?
Food And Drinks (Alcohol, Coffee, Australian Diet Context)
Topical tacrolimus produces negligible systemic exposure in most patients so interactions with food or drinks such as alcohol or coffee are unlikely.
If very large areas are treated, or skin is widely denuded, systemic absorption could theoretically rise and warrant caution.
Common Drug Conflicts
Systemic CYP3A4 inhibitors or inducers are unlikely to interact with topical tacrolimus in routine use, but caution is reasonable if systemic exposure is suspected.
Do not combine tacrolimus ointment with other topical immunosuppressants or potent topical corticosteroids on the same area without medical advice.
| Interaction Risk | Examples | Advice |
|---|---|---|
| No Clinically Significant Interaction | Alcohol, caffeine, typical Australian diet | Use as directed; no diet adjustment needed. |
| Potential Systemic Risk | Systemic immunosuppressants; potent CYP3A4 inhibitors/inducers if high systemic exposure suspected | Inform GP/pharmacist and monitor; specialist input if concerned. |
| Local Interactions | Other topical immunosuppressants, occlusive dressings, open wounds | Avoid concurrent topical agents on same site unless directed by prescriber. |
Always tell your GP or pharmacist about prescription medicines, over‑the‑counter products, supplements and complementary therapies.
User Reports & Trends
What do Australian patients say about using tacrolimus ointment for eczema?
Many users report tacrolimus as a useful steroid‑sparing option for sensitive areas such as the face, eyelids and groin.
Commonly reported effects include transient burning or stinging on application and clinical improvement within days to a few weeks.
Price sensitivity is a recurring theme and PBS subsidy expectation strongly affects access.
Rural patients often describe longer waits for specialist scripts and rely on telehealth consultations and their local pharmacist for access.
- Benefits: steroid‑sparing, suitable for sensitive skin, effective maintenance option.
- Drawbacks: transient stinging, risk of viral skin infections, cost/access issues if not subsidised.
- Access Issues: variability between pharmacies and reliance on telehealth in some areas.
Verify anecdotal reports against clinical guidance and consult a pharmacist or dermatologist for tailored advice.
Access & Purchase Options
Need to know where to get a script filled and how online ordering works in Australia?
National Chains (Chemist Warehouse, Priceline, TerryWhite)
Major pharmacy chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart can dispense tacrolimus ointment on presentation of a valid prescription.
Stock and brand ranges (0.03% or 0.1%) vary by store and supplier.
Online Pharmacies And Telehealth E‑Prescriptions
Australian pharmacies accept telehealth e‑prescriptions from authorised prescribers and many online pharmacies will dispense and deliver following receipt of a valid script.
In our online pharmacy, Protopic is available without a prescription, with discreet delivery to Australia in 9–21 days.
| Provider Type | Examples | Typical Process | PBS/Subsidy Note |
|---|---|---|---|
| National Chain | Chemist Warehouse, Priceline, TerryWhite | Present script in store or upload e‑script; home delivery available | Check PBS listing and concession eligibility at time of purchase |
| Independent Pharmacy | Local community pharmacies | Dispense with paper or electronic prescription; counselling in person | Price and stock vary by location |
| Online Pharmacy | Accredited Australian online pharmacies | Upload script/e‑prescription, courier delivery | Verify pharmacy accreditation and PBS status before purchase |
- Verify Australian pharmacy accreditation.
- Require a valid prescription unless using an advertised non‑prescription supply channel as noted above.
- Check expiry and storage instructions on delivery; use insulated transport for long hot transits if recommended.
- Rural solutions include telehealth scripts and courier delivery.
Mechanism & Pharmacology
How does tacrolimus work differently to topical steroids?
Simplified Explanation
Tacrolimus is a topical calcineurin inhibitor that reduces T‑cell activation and the release of inflammatory cytokines in atopic dermatitis lesions.
Because it is steroid‑free, tacrolimus avoids the skin‑thinning (atrophy) risk associated with prolonged topical corticosteroid use, making it especially useful on the face and other thin‑skinned areas.
Clinical Terms
- Calcineurin Inhibitor: a drug that blocks calcineurin signalling and reduces T‑cell mediated inflammation.
- ATC Code: D11AH01 for topical tacrolimus.
- Systemic Absorption: minimal when applied to intact skin; increased absorption may occur with inflamed, thin or denuded skin.
| Feature | Tacrolimus Ointment | Topical Corticosteroids |
|---|---|---|
| Mechanism | Calcineurin inhibition, T‑cell suppression | Anti‑inflammatory via glucocorticoid receptor |
| Skin Atrophy Risk | Low | Higher with prolonged use |
| Typical Use | Sensitive areas, maintenance steroid‑sparing | First‑line for acute flares |
Refer to Astellas manufacturer information and the product SPC for detailed pharmacology and regulatory statements.
Indications & Off‑Label Uses
Is tacrolimus approved for the skin condition you or your child has?
Approved Indications By TGA
Per the reviewed data and regulatory practice in comparable jurisdictions, tacrolimus topical ointment is indicated for moderate‑to‑severe atopic dermatitis in adults and children from age 2 years, with 0.03% recommended for children and 0.1% for adults/adolescents where indicated.
It is typically used as second‑line therapy when topical corticosteroids are unsuitable or for steroid‑sparing maintenance.
Off‑Label Uses In Australian Clinical Practice
Reported off‑label applications under specialist supervision include treatment for contact dermatitis, adjunctive use in vitiligo, and some other inflammatory dermatoses; evidence strength varies and specialist input is recommended.
- Approved: Moderate‑to‑severe atopic dermatitis (children ≥2 years for 0.03%, adults/adolescents ≥16 years for 0.1% as indicated).
- Off‑Label Examples: Contact dermatitis, adjunctive vitiligo therapy, selected inflammatory dermatoses under specialist guidance.
Off‑label use should be documented, consented, and based on current clinical guidance and specialist recommendations.
Key Clinical Findings
What does the evidence say about how quickly tacrolimus works and how safe it is long term?
Clinical data show that tacrolimus ointment is effective for inducing remission in moderate‑to‑severe atopic dermatitis, with many patients improving within 1–3 weeks of starting treatment.
Longer‑term safety data in selected cohorts extend to around four years with acceptable outcomes when used intermittently for maintenance.
Comparative studies demonstrate a lower risk of skin atrophy compared with topical corticosteroids.
Common adverse events reported include transient local burning or stinging and an increased risk of viral skin infections such as herpes simplex at treated sites.
- Efficacy: Rapid improvement in many patients within days to weeks.
- Safety: Well tolerated for intermittent/maintenance dosing; monitor for local infection.
- Limitations: Heterogeneous study populations and labelled warnings about theoretical cancer risk mean clinicians should follow TGA/SPC guidance.
Alternatives Matrix
Looking at other options for eczema management and how they compare?
PBS‑Listed Alternatives Comparison Table
| Agent | Mechanism | Typical Indication | Pros | Cons | PBS Status |
|---|---|---|---|---|---|
| Topical Corticosteroids | Glucocorticoid receptor agonists | Acute flares, all severities depending on potency | Fast action, widely available | Risk of skin atrophy with long‑term use | Many corticosteroids are PBS‑listed in various formulations (check current schedules) |
| Pimecrolimus (Elidel) | Topical calcineurin inhibitor | Mild‑to‑moderate atopic dermatitis; sensitive areas | Steroid‑sparing, suitable for face/eyelids | Local stinging; cost/access varies | Check PBS status for current listing |
| Crisaborole (Eucrisa) | PDE‑4 inhibitor | Mild‑to‑moderate eczema | Non‑steroidal, suitable for some patients | Variable efficacy in moderate‑severe disease; cost | Check PBS listing for subsidy details |
Pros And Cons Checklist
- Consider steroid atrophy risk versus steroid‑sparing benefits.
- Assess suitability for sensitive areas like face and eyelids.
- Factor in onset of action, cost and PBS coverage when choosing therapy.
- Engage in shared decision‑making and involve a dermatologist for refractory cases.
Common Questions
Here are the short answers to questions we hear at the pharmacy every week.
- Is tacrolimus safe long‑term? Yes for maintenance in selected patients when monitored and used intermittently as per guidance.
- Can I use it on my face or eyelids? Yes — tacrolimus is often preferred over steroids on thin skin, but expect transient stinging.
- What about pregnancy? Use only if the expected benefit justifies the potential risk; speak to your GP or specialist.
- Can children use it? 0.03% is approved from age 2 years; specialist oversight is recommended for younger children or complex cases.
Checklist To Bring To Your Pharmacy:
- Current medicines and supplements list.
- Known allergies and sensitivity history.
- Exact areas you want to treat and any skin infections to report.
- Pregnancy or breastfeeding status if applicable.
For complex queries, the pharmacist will recommend GP or dermatologist follow‑up and refer to the SPC and TGA guidance where necessary.
Price & Access Comparison Table
Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required
| Source | Examples | Typical Price Range | PBS Subsidy | Prescription Required |
|---|---|---|---|---|
| National Chain | Chemist Warehouse, Priceline | Varies by supplier; check current prices with the pharmacy | Check PBS for up‑to‑date listing and eligibility | Yes |
| Independent Pharmacy | Local community pharmacies | Price varies regionally; ask your pharmacist for a quote | Conditional on PBS listing and patient eligibility | Yes |
| Online Pharmacy | Accredited Australian online suppliers | Comparable to in‑store prices; check delivery fees | Depends on PBS status and supplier processes | Yes, or see noted exceptions in purchase context |
Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability
- Have a current prescription ready or arrange a telehealth consult for an e‑prescription.
- Check PBS eligibility and your concession card status to reduce out‑of‑pocket costs.
- For rural patients, consider telehealth scripts and courier delivery options.
- Verify online pharmacy accreditation and that a valid prescription is required on supply.
Registration & Regulation
How is tacrolimus regulated in Australia and where to check current status?
TGA Approval
Tacrolimus topical formulations must comply with TGA registration requirements to be marketed in Australia; check the Australian Register of Therapeutic Goods (ARTG) for current sponsor and product entries.
PBS Subsidy Details
PBS subsidy for tacrolimus topical products depends on current listings and approved indications; verify live PBS schedules for eligibility and any prescribing restrictions before advising patients on cost.
- TGA: Therapeutic Goods Administration — national regulator for medicines.
- ARTG: Australian Register of Therapeutic Goods — database of registered products.
- PBS: Pharmaceutical Benefits Scheme — check for subsidy status and authority requirements.
Labelled warnings include theoretical cancer risk in immunocompromised patients and contraindications such as active skin infections; consult the SPC for full regulatory cautions.
Storage & Handling
How should you store tacrolimus ointment at home and what should pharmacies do in hot Australian conditions?
Household Storage In Australian Climate (Heat/Humidity)
Store tacrolimus ointment below 25°C and do not freeze the tube.
Keep the tube tightly closed, protected from light and out of reach of children.
In hot or humid Australian weather avoid storing the ointment in a bathroom or a car glovebox on hot days; choose a cool, shaded cupboard instead.
Cold‑Chain Handling For Pharmacies
Pharmacies should store stock within recommended ambient conditions, monitor storage temperature logs if required and check expiries regularly.
When dispatching to patients in hot climates or during long transit, consider insulated packaging or expedited courier options and counsel patients on storage on receipt.
- Typical unopened shelf life is around three years; after opening, check the carton but many products indicate about 12 months — verify the package insert.
- Dispose of unused ointment per local medication disposal guidance.
Guidelines For Proper Use
What should the pharmacist tell a patient when handing over tacrolimus ointment?
Australian Pharmacist Counselling Style
Confirm the indication, appropriate concentration and patient age before supply.
Demonstrate applying a pea‑sized or thin layer and explain twice daily use during flares and maintenance dosing once or twice weekly if prescribed for prevention.
Warn about common transient stinging, signs of infection to watch for, and to avoid mucous membranes, open wounds and occlusion.
Patient Advice From PBS And National Health Authorities
- Apply exactly as prescribed and stop when the skin is clear unless instructed to continue maintenance dosing.
- Wash hands after applying unless treating the hands themselves.
- Avoid excessive sun or UV exposure on treated skin and use sunscreen on unaffected areas as advised.
- Seek GP or pharmacist review if infection signs, worsening rash, or systemic symptoms occur.
Provide a follow‑up organiser: review with GP in 2–4 weeks during induction, sooner if adverse effects develop, and earlier referral to dermatology for treatment failure.
Delivery Across Australia
| City | Region | Delivery time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Gold Coast | Queensland | 9-14 days |
| Newcastle | New South Wales | 9-14 days |
| Wollongong | New South Wales | 9-14 days |
| Sunshine Coast | Queensland | 14-21 days |
| Geelong | Victoria | 14-21 days |
| Townsville | Queensland | 14-21 days |
| Cairns | Queensland | 14-21 days |